P/E at 58.74 vs Industry's 66.35: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount Amidst Sector Premiums

The hospital sector currently trades at an average P/E of 66.35, reflecting elevated investor expectations for growth and profitability. Against this backdrop, Apollo Hospitals Enterprise Ltd. stands out with a P/E of 58.74, representing a discount of approximately 11.5% relative to its peers. This valuation gap suggests that the market is pricing in either a more cautious outlook on the company’s near-term earnings trajectory or recognising a relatively more conservative growth profile compared to the broader sector. Apollo Hospitals Enterprise Ltd.’s sizeable market capitalisation of ₹1,24,805.08 crores further underscores its status as a large-cap stalwart within the hospital industry.

Performance Across Timeframes: Divergent Momentum

Examining returns across multiple time horizons reveals a complex performance narrative. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a 10.99% gain, significantly outperforming the Sensex’s 3.49% loss during the same period. This outperformance extends over longer durations, with three-year and five-year returns at 80.14% and 113.78% respectively, dwarfing the Sensex’s 18.93% and 40.31% gains. The ten-year return is particularly striking at 512.78%, reflecting the company’s sustained growth over the past decade.

However, shorter-term results paint a more cautious picture. The stock has declined by 3.35% over the past week and 2.48% in the last month, underperforming the Sensex’s modest gains of 0.91% and 0.94% respectively. The three-month return of 6.95% still outpaces the Sensex’s 3.16%, but the recent weekly and monthly dips suggest some near-term pressure. The stock’s year-to-date performance remains robust at 23.25%, contrasting with the Sensex’s 8.73% decline. This divergence raises the question of whether recent weakness is a temporary correction or indicative of emerging challenges — is this a short-term pause or a shift in momentum for Apollo Hospitals?

Moving Average Configuration: Mixed Technical Signals

The technical landscape for Apollo Hospitals Enterprise Ltd. is equally nuanced. The stock currently trades above its 100-day and 200-day moving averages, signalling that the longer-term trend remains intact and supportive. However, it is positioned below its 5-day, 20-day, and 50-day moving averages, indicating recent short-term weakness or consolidation. This configuration often suggests a recovery phase within a broader uptrend or a temporary pullback after a rally. The stock has recorded gains over the last two days, rising 0.97%, which may hint at a nascent rebound — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Sector Performance Context: Hospital Industry Trends

The hospital sector has experienced a mixed performance landscape recently, with a blend of positive, flat, and negative results across constituent stocks. The elevated sector P/E of 66.35 reflects investor optimism about growth prospects, driven by rising healthcare demand and innovation. Within this environment, Apollo Hospitals Enterprise Ltd.’s valuation discount and relative performance suggest it is navigating sector headwinds with some resilience. The stock’s ability to outperform the Sensex over multiple timeframes while trading below the sector P/E ratio may indicate a more measured growth outlook or a cautious market stance on near-term earnings expansion.

Rating Reassessment: Previously Hold, Now Updated

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Hold rating by MarketsMOJO. This reassessment reflects a comprehensive review of the company’s fundamentals, valuation, and technical indicators. The current Mojo Score stands at 77.0, signalling a positive outlook relative to its prior assessment. The rating update invites investors to consider how the new evaluation aligns with the stock’s recent performance and valuation metrics — should investors in Apollo Hospitals hold, buy more, or reconsider?

Collective Data Insights: Balancing Valuation and Momentum

Bringing together valuation, performance, technicals, and rating context, Apollo Hospitals Enterprise Ltd. presents a compelling case of a large-cap hospital stock trading at a valuation discount to its sector peers while delivering consistent long-term outperformance. The recent short-term softness, reflected in weekly and monthly returns, contrasts with the sustained gains over one, three, five, and ten years. The mixed moving average configuration further highlights a stock in a phase of consolidation or minor correction within a broader uptrend. The rating update from Hold to a more positive stance underscores this nuanced picture, inviting a closer look at the company’s fundamentals and market positioning — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Overall, the data suggests that while Apollo Hospitals Enterprise Ltd. remains a strong performer in the hospital sector, investors should weigh the recent short-term volatility against its longer-term growth trajectory and valuation discount.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today